Next Generation Natural Killer Cells for Cancer Immunotherapy

Next Generation Natural Killer Cells for Cancer Immunotherapy

In recent years, immunotherapy for cancer has become mainstream with several products now authorized for therapeutic use in the clinic and are becoming the standard of care for some malignancies. Chimeric antigen receptor (CAR)-T cell therapies have demonstrated substantial efficacy for the treatmen...

Full description

Bibliographic Details
Main Authors:	Fiorella Rossi, Nathaniel Fredericks, Andrew Snowden, Michael J. Allegrezza, Uriel Y. Moreno-Nieves
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Immunology
Subjects:	NK cell iPSC (induced pluripotent stem cell) CAR (chimeric antigen receptor) engineering stealth
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.886429/full

Similar Items

iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
by: Benjamin H. Goldenson, et al.
Published: (2022-02-01)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
by: Siyao Liu, et al.
Published: (2022-12-01)

Natural killer cells: the next wave in cancer immunotherapy
by: Xin Chen, et al.
Published: (2022-07-01)

Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
by: Jin-he Jiang, et al.
Published: (2024-01-01)

Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
by: Ji-nuo Wang, et al.
Published: (2022-09-01)

Genome editing iPSC to purposing enhancement of induce CD8 killer T cell function for regenerative immunotherapy
by: Sota Kurihara, et al.
Published: (2024-04-01)

Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments
by: Yoshikazu Kishino, et al.
Published: (2023-03-01)

Efficacy of MUC1-targeted CAR-NK cells against human tongue squamous cell carcinoma
by: Xiaolan Lin, et al.
Published: (2024-02-01)

Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells
by: Phatchanat Klaihmon, et al.
Published: (2023-06-01)

CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01)

Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies
by: Siyu Su, et al.
Published: (2022-05-01)

Utilizing chimeric antigen receptors to direct natural killer cell activity
by: Dan S Kaufman, et al.
Published: (2015-04-01)

Adoptive Immunotherapy beyond CAR T-Cells
by: Aleksei Titov, et al.
Published: (2021-02-01)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
by: Omer Hatim, et al.
Published: (2023-12-01)

The EBiSC iPSC bank for disease studies
by: Rachel Steeg, et al.
Published: (2020-12-01)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56brightCD16+NKp80+/-In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
by: Johanna Euchner, et al.
Published: (2021-05-01)

Episomal vector reprogramming of human umbilical cord blood natural killer cells to an induced pluripotent stem cell line MUSIi013-A
by: Phatchanat Klaihmon, et al.
Published: (2021-08-01)

NK cell-based cancer immunotherapy: from basic biology to clinical development
by: Sizhe Liu, et al.
Published: (2021-01-01)

Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
by: Takeshi Tokuyama, et al.
Published: (2021-09-01)

Induced pluripotent stem cell-based therapies for organ fibrosis
by: Wei Cheng, et al.
Published: (2023-05-01)

CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
by: Marta Włodarczyk, et al.
Published: (2022-12-01)

An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells
by: Li-Jie Hsu, et al.
Published: (2021-09-01)

Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
by: Shin Yi Tang, et al.
Published: (2021-11-01)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Kevin Pan, et al.
Published: (2022-03-01)

Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene
by: Irina Panchuk, et al.
Published: (2022-10-01)

Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
by: Carlos Moreno, et al.
Published: (2022-06-01)

Human iPSC banking: barriers and opportunities
by: Ching-Ying Huang, et al.
Published: (2019-10-01)

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
by: Yang Zhou, et al.
Published: (2022-05-01)

Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
by: Ahmed Salah, et al.
Published: (2021-06-01)

Natural killer cells: a promising immunotherapy for cancer
by: Junfeng Chu, et al.
Published: (2022-05-01)

Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
by: Maryam Bahmanyar, et al.
Published: (2022-11-01)

Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
by: Sherida de Leeuw, et al.
Published: (2019-07-01)

Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)
by: Nityanand Prakash, et al.
Published: (2023-04-01)

Generation of two iPSC lines from patient with Mucopolysaccharidosis IV B type and autosomal recessive non-syndromic hearing loss 12
by: I.O. Panchuk, et al.
Published: (2023-09-01)

CAR-T: What Is Next?
by: Yi-Ju Chen, et al.
Published: (2023-01-01)

Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
by: Li Zhang, et al.
Published: (2020-11-01)

A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics
by: Irene Gallego Romero, et al.
Published: (2015-06-01)

Isolation of Diverse Simian Arteriviruses Causing Hemorrhagic Disease
by: Teressa M. Shaw, et al.
Published: (2024-04-01)

Human iPSC-derived glia models for the study of neuroinflammation
by: Nina Stöberl, et al.
Published: (2023-10-01)

Sporadic Parkinson’s disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs
by: Markus Schulze, et al.
Published: (2018-07-01)